Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
ISOSORBIDE MONONITRATE
Profind Wholesale Ltd.
60 Milligram
Film Coated Tablet
2009-08-21
IRISH MEDICINES BOARD ACT 1995, AS AMENDED MEDICINAL PRODUCTS (CONTROL OF PLACING ON THE MARKET) REGULATIONS, 2007, AS AMENDED PPA1500/028/001 Case No: 2083742 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to PROFIND WHOLESALE LTD. UNIT 625, KILSHANE AVENUE, NORTHWEST BUSINESS PARK, DUBLIN 15, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product IMDUR 60 MG PROLONGED-RELEASE TABLETS the particulars of which are set out in the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 28/07/2010. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 28/07/2010_ _CRN 2083742_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Imdur 60 mg Prolonged-Release Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 60 mg isosorbide mononitrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated, prolonged-release tablet _Product imported from Greece:_ Yellow oval, biconvex, tablet, scored on both sides and engraved with ‘A’ and ‘ID’ on one side 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prophylactic management of angina pectoris. Imdur is not indicated in the management of acute attacks of angina pectoris. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION DOSAGE Imdur 60 mg once daily to be taken Прочитайте повний документ